NCT00721240View on ClinicalTrials.gov

Investigation to Identify Predictors of Response to a Treatment With Montelukast

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

June 30, 2009

Conditions
Asthma
Interventions
DRUG

montelukast

5mg montelukast once daily for 12 weeks

Trial Locations (1)

46483

Marien Hospital Wesel gGmbH, Wesel

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Marien Hospital Wesel

OTHER

NCT00721240 - Investigation to Identify Predictors of Response to a Treatment With Montelukast | Biotech Hunter | Biotech Hunter